Woven Science’s El Puente foundation is pleased to release for public comment its policy paper and corporate social responsibility initiative for psychedelic pharmaceutical companies to engage with indigenous peoples using psychedelic botanicals in traditional practice. This paper explores how public
Registration now open to the only global multidisciplinary conference featuring world-class speakers, cutting-edge research presentations, case study reviews and more specifically in the field of Atopic Dermatitis CHICAGO, Oct. 19, 2021 (GLOBE NEWSWIRE) — The 3rd Annual Live Revolutionizing Atopic
As WM has already developed and tested its functioning Global, Digital and multicurrency Digital currency for nearly a decade, it is aware of all the capacities of such instruments, and the responsibilities that go hand-in-hand with its creation and usage
Ambulero Inc Receives Key FDA Recognition For Novel Gene Therapy To Treat Buerger’s Disease (Thromboangiitis Obliterans) MIAMI, Oct. 19, 2021 (GLOBE NEWSWIRE) — Ambulero Inc., a biotechnology company (“Ambulero” or the “Company”) developing new cell and gene therapy treatments for
Unified Top Companies Bring Unmatched Global Capabilities for Workplace Experience BOSTON, Oct. 19, 2021 (GLOBE NEWSWIRE) — HqO, the end-to-end tenant experience platform for commercial real estate properties, today announces that it has acquired Office App, a leading European tenant
The annual awards celebrate the beauty of the microscopic world through imaging Olympus Image of the Year Award 2021 WALTHAM, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — Olympus’ third annual Global Image of the Year Life Science Light Microscopy Award
New report from RedThread Research and Degreed uncovers the actionable skills that build more diverse organizations, including assertiveness, grit, authenticity, and curiosity PLEASANTON, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) — A new report, Creating a DEIB Culture: The Skills Every
Data to be presented at the 2021 ISIRV-WHO Virtual Conference WALTHAM, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases
